InFlectis BioScience Announces Publication of Groundbreaking Study on IFB-088's Therapeutic Potential in ALS in Life Science Alliance

InFlectis BioScience Announces Publication of Groundbreaking Study on IFB-088's Therapeutic Potential in ALS in Life Science Alliance

Nantes, France--(Newsfile Corp. - July 2, 2025) - InFlectis BioScience, a clinical-stage biotechnology company focused on developing

An author discusses ALS and how she became an activist

Mindy Uhrlaub, an author and activist for amyotrophic lateral sclerosis (ALS), has spent a good part of her life caring for loved ones. Soon after she became a mom in 2003, her husband learned he had cancer. “Right as my older son was taking his first wobbly steps, my husband was diagnosed with the first cancer that he had,” says Uhrlaub, who lives in San Anselmo, Calif. “So I’ve been in this role for a really long time.” In her new book, “Last …